BioCryst to Present at Upcoming Investor Conferences

Rhea-AI Summary

BioCryst Pharmaceuticals (Nasdaq: BCRX) has announced its participation in two major upcoming investor conferences in March 2025. The company will present at the TD Cowen 45th Annual Health Care Conference in Boston on March 5 at 9:10 a.m. ET, and at the Barclays 27th Annual Global Healthcare Conference in Miami on March 11 at 10:00 a.m. ET.

Investors and interested parties can access live audio webcasts and replay recordings of both presentations through the Investors & Media section of BioCryst's website at biocryst.com.

News Market Reaction – BCRX

+0.32%

+0.32% Session move

In the trading session that priced this news, BCRX gained 0.32%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

RESEARCH TRIANGLE PARK, N.C., Feb. 19, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the following conferences:

• TD Cowen 45^th Annual Health Care Conference in Boston on Wednesday, March 5, 2025, at 9:10 a.m. ET.
  
• Barclays 27^th Annual Global Healthcare Conference in Miami on Tuesday, March 11, 2025, at 10:00 a.m. ET.
  

Links to the live audio webcasts and replays of the presentations may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.

About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with complement-mediated and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO^® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.

BCRXW

Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com

FAQ

When is BioCryst (BCRX) presenting at the TD Cowen Healthcare Conference in 2025?

BioCryst (BCRX) will present at the TD Cowen 45th Annual Health Care Conference in Boston on Wednesday, March 5, 2025, at 9:10 a.m. ET.

What time is BCRX presenting at the Barclays Healthcare Conference in March 2025?

BioCryst (BCRX) will present at the Barclays 27th Annual Global Healthcare Conference in Miami on Tuesday, March 11, 2025, at 10:00 a.m. ET.

How can investors access BioCryst's (BCRX) conference presentations in March 2025?

Investors can access live audio webcasts and replays of the presentations through the Investors & Media section of BioCryst's website at biocryst.com.

Which investor conferences is BCRX attending in March 2025?

BCRX is attending two conferences: the TD Cowen 45th Annual Health Care Conference in Boston and the Barclays 27th Annual Global Healthcare Conference in Miami.